text: .@US_FDA @NIH @NIHDirector need to prioritize immune response testing and research. We still have a lot of unanswered questions on infection-acquired and vaccine-acquired immune response and how to chart path forward on boosters, durability, effectiveness on variants: https://t.co/KhsDuGZ2Kx